J. Goldman & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.94M | Buy |
+85,205
| New | +$3.94M | 0.09% | 167 |
|
|
2025
Q1 | – | Sell |
-143,434
| Closed | -$8.11M | – | 333 |
|
|
2024
Q4 | $8.11M | Buy |
+143,434
| New | +$8.11M | 0.21% | 117 |
|
|
2024
Q3 | – | Sell |
-415,461
| Closed | -$17.3M | – | 344 |
|
|
2024
Q2 | $17.3M | Buy |
+415,461
| New | +$17.3M | 0.49% | 52 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 249 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 259 |
|
|
2023
Q1 | – | Sell |
-137,061
| Closed | -$9.86M | – | 258 |
|
|
2022
Q4 | $9.86M | Buy |
+137,061
| New | +$9.86M | 0.48% | 49 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 273 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 242 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 186 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 172 |
|
|
2018
Q1 | – | Sell |
-9,276
| Closed | -$568K | – | 244 |
|
|
2017
Q4 | $568K | Buy |
+9,276
| New | +$568K | 0.03% | 165 |
|
|
2017
Q2 | – | Sell |
-600
| Closed | -$33K | – | 197 |
|
|
2017
Q1 | $33K | Buy |
+600
| New | +$33K | ﹤0.01% | 200 |
|